Head for the Cure was honored to be a part of the annual Brain Tumor Trials Collaborative (BTTC) annual meeting in March. Read more about the lates brain tumor trials.
The BTTC has grown to more than 23 member institutions and has experienced unparalleled advancements in the research of alternative treatments of malignant brain tumors. Research studies, also known as clinical trials, are being conducted to learn of promising advances to cancer prevention, diagnosis and treatments that are safe and effective.
Funds raised through the Head for the Cure Foundation provided the seed money to help launch the BTTC. And Head For the Cure remains committed to supporting the BTTC and its mission with ongoing financial support.